Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biocancell Therapeutics Inc. (BICL.TA) since 2012 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biocancell Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1451980.
Total stock buying since 2012: $4,460,628.
Total stock sales since 2012: $0.
Total stock option exercises since 2012: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 18,931,126 | $4,460,628 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-07 | 10,731,726 | $2,328,784 | 0 | $0 | 0 | $0 |
| 2012-01 | 8,199,400 | $2,131,844 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-07-31 | Clal Biotechnology Industries Ltd. | Buy | 10,731,726 | .22 | 2,328,784 |
| 2012-01-24 | Livnat Avraham | Buy | 8,199,400 | .26 | 2,131,844 |
Insider trading activities including stock purchases, stock sales, and option exercises of BICL.TA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biocancell Therapeutics Inc. (symbol BICL.TA, CIK number 1451980) see the Securities and Exchange Commission (SEC) website.